NSETrading Window3h ago · 25 Sept 2026, 03:36 pm
Trading Window
Rossari Biotech Limited · ROSSARI
✦ AI SummaryRegulatory
Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed for all designated persons and their immediate relatives from October 1, 2026, till 48 hours after the announcement of unaudited financial results for the quarter and half year ending on September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
ROSSARI_25092026153554_20260925_Intimation_for_Closure_of_Trading_Window_30092026.pdf
View document text
September 25, 2026
DCS-CRD Listing Compliance
BSE Limited National Stock Exchange of India Limited
First Floor, New Trade Wing Exchange Plaza, 5th Floor
Rotunda Building, Phiroze Jeejeebhoy Towers Plot No. C/1, ‘G’ Block, Bandra- Kurla Complex
Dalal Street, Fort Mumbai 400001 Bandra East Mumbai 400051
Fax No.2272 3121/2037/2039 Fax No.2659 8237/8238
Stock Code: 543213 Stock Code: ROSSARI
Dear Sir/Madam,
Sub: Closure of Trading Window
With regard to the captioned matter, this is to inform you that pursuant to the provisions of Securities
and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended and
Company’s Code of Conduct for Prevention of Insider Trading (“Code of Conduct”), the “Trading
Window” for dealing in securities of the Company shall remain closed for all the “Designated Persons
and their immediate relatives” covered under the Code of Conduct, from October 01, 2026 till 48 hours
after the announcement of Unaudited Financial Results of the Company for the quarter and half year
ending on September 30, 2026.
The same is being informed to the Designated Persons and their immediate relatives in accordance with
the Code of Conduct.
The details of the date of the Board Meeting for consideration and approval for aforesaid financial
results shall be intimated in due course.
The same may please be taken on record and suitably disseminated to all concerned.
Thanking you,
Yours Sincerely,
For Rossari Biotech Limited
Parul Gupta
Company Secretary & Head - Legal
Membership No.: A38895